Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition
The company will gain access to HI-Bio’s lead asset for immune-mediated and rare diseases
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Johnson & Johnson shares positive phase 3 results for Tremfya versus Stelara in Crohn’s disease
The GALAXI programme comprises three trials evaluating the IL-23 inhibitor in the IBD condition
Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition
The company will gain access to HI-Bio’s lead asset for immune-mediated and rare diseases
WHO updates drug-resistant bacteria list to develop new treatments for AMR
The 2024 BPPL list includes 15 families of antibiotic-resistant bacteria
GSK becomes first founding partner of global initiative tackling antimicrobial resistance
AMR could cause an estimated ten million deaths every year by 2050 unless action is taken
PMLiVE’s T40 – open for submissions!
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
Latest content
Gilead Sciences appoints Peter Wickersham to vice-president and general manager in the UK and Ireland
Wickersham recently led Gilead’s liver disease and COVID-19 business unit in the US
Read More
Intelligence
Chasing the alchemy of trial diversity with a mix of culture change and practical mechanics
Industry needs to follow functional realignment to empower a culture change
Read More
Women in pharma
Iona Everson from PMGroup spoke to Ioana Parsons, general manager of Ipsen UK and Ireland, about her career path and her experiences working in pharma
Read More
Achieving patient-guided drug development: putting the patient experience first
Why understanding all aspects of the patient journey is imperative to successful clinical research
Read More
Data integration and the AI healthcare revolution
Looking at some of the chief opportunities and challenges for digital health providers in implementing and scaling technological solutions in the UK
Read More
Is the gut microbiome the next frontier in medicine?
Research has long shown a strong connection between disease and the gut microbiome
Read More
Current trends and the renaissance of Alzheimer’s drug development
With 14 million people in Europe expected to suffer from Alzheimer’s and other forms of dementia by 2030, the race is on to find a treatment to not only slow its course, but even prevent the development of the disease
Read More
Blogs
Latest
Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care
May 23, 2024 | Medscape Education Global|CME, Education, Nephrology, kidney, medical education
Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series …
Why healthcare and pharma businesses need video marketing
May 21, 2024 | Wallace Health|Health Shelf, Omnichannel marketing, Video content
Video has become such a major part of our online experiences that omnichannel marketing can’t really happen without it. And that goes for every industry, …
How social media is censoring women’s health content
May 21, 2024 | Wallace Health|Health content, social media censorship, women's health
At Wallace Health we’re passionate about the power of content and how it can change behaviour and improve lives. Along with our clients, we understand …
Medscape Brings Impact and Data to ESPGHAN
May 20, 2024 | Medscape Education Global|Publications, impact, medical education
The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters …
Empowering Nurses Through Education
May 17, 2024 | Medscape Education Global|CME, Education, Nursing, medical education
Nurse education is powerful and makes an impact.
PUTTING RARE DISEASE UNDER THE MICROSCOPE: WHY A DEEPER UNDERSTANDING OF GENETICS COUNTS
May 21, 2024 | IGNIFI|
Our genetic makeup has a significant role in health and disease. In this blog, we will explore how well we understand the genetic components of …
Exploring medical education and why it relies on real-world research
May 16, 2024 | Onyx Health|HCP engagement, MedEd, healthcare communications, medical education
Onyx Health’s Head of Medical Education, Sarah Seilly, explains our approach to MedEd and the benefits of tailoring your own
Beyond the AI anxiety: The impact of human intuition
May 7, 2024 | Mednet Group|AI, Innovation, Project Management, artificial intelligence, thought leadership
Explore the ways we’re adapting to work with AI, not against it
Navigating the rapidly changing oncology treatment landscape: how digital tools can help
May 2, 2024 | Impetus Digital|Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…
The role of economic evaluation in US healthcare
April 30, 2024 | Mtech Access|AMCP, Health Economics, ICER, US healthcare, USA, health economic evaluation
Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight …
Boosting Engagement with Fun: Asynchronous Touchpoints – Impetus InSite Tips for Optimizing Asynchronous Virtual Meetings
May 9, 2024 | Impetus Digital | DOL, HCP advisor, HCP engagement, Healthcare Events, Healthcare Meetings, Impetus Digital, KOL, Pharma meetings, Pharma tips, Pharma trends, Pharme events, Virtual advisory boards, advisor engagement, virtual meetings